The Pharma Letter7h
Italfarmaco’s Duvyzat backed by MHRA
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted a conditional marketing authorization for ...
The Pharma Letter6h
FDA approves Novo Nordisk’s Alhemo
Denmark’s Novo Nordisk said late Friday that the US Food and Drug Administration (FDA) has approved Alhemo (concizumab-mtci) ...
The Pharma Letter17h
The week in pharma: action, reaction and insight – week to December 20
Among significant research news last week, UK drug developer PureTech released positive new Phase IIb data on its ...